One (7.1%) died during the early postoperative period (30 days), while the other died shortly after discharge from hospital.
Five of these patients had suffered intraoperative or postoperative problems or had a re-operation.
Our report discusses policies for postoperative prophylaxis as well as treatment of the acute thrombosis, including thrombolytic therapy with tissue plasminogen activator.
The effects of delirium on postoperative functional status were assessed in conjunction with postoperative depressive symptoms using regression models.
Postoperative injection at the site of the anastomosis between the homograft and the pulmonary arteries shows dilatation of the homograft with pulmonary regurgitation.
Importantly, no unique technical issues relative to deployment were found in the immediate postoperative period, although complications can occur.
In addition, 9% of patients died, 9% developed seizures, and 18% had significant postoperative infections.
Two patients developed permanent postoperative atrioventricular block requiring insertion of a pacemaker.
